Business Context and Reporting Period
This Form 10-Q is for Bioflamex Corporation, a Nevada development-stage company, for the three and six months ended August 31, 2012. The request metadata identifies Cann American Corp. and “2011 Q2,” which does not match the filing text and should be verified.
The company is developing, producing, and marketing environmentally friendly biological fire-extinguishing and prevention products. It reported no revenue since inception on August 25, 2004. The filing also describes a proposed merger with Terra Asset Management, Inc.; the transaction was terminated on October 17, 2012.
Financial Condition and Results
| Metric | Three months ended August 31, 2012 | Six months ended August 31, 2012 | Comparable period |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| Operating expenses | $87,603 | $297,202 | $214,324 and $295,956, respectively |
| Net loss | $509,882 | $874,124 | $215,441 and $299,026, respectively |
| Operating cash flow | Not provided for the quarter | $(284,566) | $(49,963) |
- Gross and operating margins are not meaningful because the company had no revenue.
- As of August 31, 2012, total assets were $921,875, including $791,000 of net intangible assets and $126,000 due from Terra Asset Management.
- Current liabilities were $281,244, compared with current assets of $4,875, resulting in a working capital deficit of $276,369.
- Cash was effectively zero; the balance sheet reported a $251 bank overdraft at August 31, 2012.
- Convertible loans payable were $171,737, with additional related-party and other debt obligations. Total liabilities were $281,244.
- Accumulated deficit since inception was $2,881,302.
- The company had 177,603,871 shares outstanding at August 31, 2012 and 177,770,540 shares outstanding as of October 15, 2012.
Material Changes Versus the Prior Comparable Period
- Six-month operating expenses were broadly stable, increasing from $295,956 to $297,202, but the composition changed substantially: consulting expense declined to $76,398 from $248,479, while related-party compensation increased to $160,000 from zero.
- The six-month net loss increased to $874,124 from $299,026, primarily because of a $400,000 impairment charge, $169,136 of finance costs, and higher compensation and interest expense.
- Six-month operating cash usage increased to $284,566 from $49,963.
- During the period, the company issued substantial common stock for debt conversions, financing costs, consulting, executive compensation, and other services. Magna converted debt into 13,034,501 shares, and additional shares were issued in connection with MDS-related obligations.
- Intangible assets declined from $1,191,000 at February 29, 2012 to $791,000 after the $400,000 impairment.
- Prior-period financial statements were restated for previously unrecorded expenses and related errors, including increases to consulting expense and liabilities.
Guidance, Outlook, Risks, Contingencies, and Unusual Items
- Management expected continued substantial losses and did not expect profitability in the near future.
- The company stated that it required a cash injection of approximately $2,000,000 to continue operations, manufacture and deliver products, fund marketing, and pursue revenue generation.
- Management identified substantial doubt about the company’s ability to continue as a going concern. Future operations depend on additional debt or equity financing, successful product development, sales, and expense control.
- The company entered into an equity investment agreement with Dutchess Opportunity Fund II for potential purchases of up to $10,000,000 of common stock over 36 months, subject to conditions including an effective registration statement. The filing states there were no formal commitments to provide operating funds as of August 31, 2012.
- Management was preparing initial production batches of Bioflamex aerosol extinguishers and pursuing distribution, UL, and DIN certifications. Supplier and production-partner arrangements were described as drafted or otherwise not fully finalized.
- The Sentinel forest-fire detection and suppression system was delayed following the death of a key development partner, and the company was seeking alternative partners.
- The company recorded $400,000 of impairment to intellectual property and recognized significant non-cash compensation and financing costs through share issuances.
- Disclosure controls were ineffective because of inadequate segregation of duties, risk assessment, and written accounting and reporting procedures. Management stated that remediation depended on obtaining additional financing.
- The filing reported no pending legal proceedings and no off-balance-sheet arrangements.
Important Facts for Investors to Verify
- Confirm the correct issuer and reporting period, since the filing is for Bioflamex Corporation and August 31, 2012, not Cann American Corp. or 2011 Q2.
- Verify the status and terms of the terminated Terra Asset Management merger, including the $126,000 receivable and $65,700 MDS obligation retained by Bioflamex.
- Assess whether the Dutchess equity facility became available, whether its registration requirements were satisfied, and the potential dilution from future draws.
- Review the terms, maturity dates, interest rates, and conversion discounts of outstanding convertible notes and other debt.
- Evaluate the recoverability of the remaining $791,000 intellectual-property asset after the impairment charge.
- Determine whether the company secured the stated $2,000,000 funding requirement and whether it achieved product certification, production, distribution, or revenue milestones.
- Monitor remediation of the disclosed material weaknesses in internal controls and any subsequent restatements.